申请人:TAIHO PHARMACEUTICAL CO., LTD.
公开号:EP0605729A1
公开(公告)日:1994-07-13
An oxazolidine derivative represented by general formula (I), a salt thereof, a process for the production thereof, an antihyperlipidemic containing the same as the active ingredient, and a method of curing hyperlipidemia by administering the same, wherein R¹, R² and R³ represent each H, optionally halogenated alkyl, optionally halogenated alkoxy, OH, halo, NO₂, optionally acetylated or alkylated amino, COOH, alkoxycarbonyl, CN, alkanoyl or 2-oxazolyl, provided that R¹ and R² may be combined with each other to represent -(CH₂)p- or -O-(CH₂)q-O-, wherein p represents 3 to 5 and q represents 1 to 3, thus forming a cyclic structure; m and n represent each 0 or 1; R⁴ and R⁵ represent each H or alkyl; X represents C or N; Y represents CH₂OH, CHO or COOR⁶, R⁶ representing alkyl, benzyl or H; A represents alkylene, carbonyl or sulfonyl; B represents alkylene; E represents optionally halogenated alkylene or alkenylene; and Z represents O or S; provided that the case where n is 0, m is 1 and Y is CH₂OH and the case where n is 0 and Y is COOR⁶, R⁶ being alkyl, are excluded.
一种由通式(I)代表的噁唑烷衍生物、其盐、其生产工艺、一种以其为有效成分的抗高血脂药物以及一种通过服用其治疗高血脂症的方法,其中R¹、R²和R³分别代表H、任选卤代烷基、OH、卤代、NO₂、任选乙酰化或烷基化氨基、COOH、烷氧基羰基、CN、烷酰基或2-氧代烷基、任选卤代烷氧基、OH、卤代、NO₂、任选乙酰化或烷基化氨基、COOH、烷氧羰基、CN、烷酰基或 2-噁唑基,条件是 R¹ 和 R² 可以相互结合代表-(CH₂)p-或-O-(CH₂)q-O-,其中 p 代表 3 至 5,q 代表 1 至 3,从而形成环状结构;m 和 n 分别代表 0 或 1;R⁴ 和 R⁵ 分别代表 H 或烷基;X 代表 C 或 N;Y 代表 CH₂OH、CHO 或 COOR⁶,R⁶ 代表烷基、苄基或 H;A 代表亚烷基、羰基或磺酰基;B 代表亚烷基;E 代表任选卤代亚烷基或烯基;Z 代表 O 或 S;但不包括 n 为 0、m 为 1 和 Y 为 CH₂OH 的情况,以及 n 为 0 和 Y 为 COOR⁶(R⁶ 为烷基)的情况。